

Legend Biotech (LEGN) shares drop in premarket trading after pricing a $226M public offering. Get the latest technical levels here.
You can purchase shares of Legend Biotech (NASDAQ:LEGN) through any online brokerage.
Other companies in Legend Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Legend Biotech has a consensus price target of $63.90.
The stock price for Legend Biotech (NASDAQ: LEGN) is $23.05 last updated November 6, 2026 at 9:30 AM EST.
There are no upcoming dividends for Legend Biotech.
Legend Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for Legend Biotech.
Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen...